Matthew J. Hawryluk Ph.D

Matthew J. Hawryluk Ph.D Predictive Oncology

  (Eagan, MN)  — Dec. 05, 2022  — Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D. to its Board of Directors to help support the company’s strategic initiatives and commercialization efforts. Dr. Hawryluk currently serves as Executive Vice President and Chief Business Officer of Gritstone bio, Inc Recognized by Pharmaceutical Executive magazine as a leading business executive in the pharma and biotech